Hardman Johnston Global Advisors LLC Alkermes Plc. Transaction History

Hardman Johnston Global Advisors LLC

$2.46 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$26.4 - $32.56 $74 Million - $91.2 Million	-2,801,520 Reduced 51.16%	2,674,735 $72.4 Million
Q4 2023 Jan 29, 2024	SELL	$23.37 - $28.68 $3.08 Million - $3.78 Million	-131,809 Reduced 2.35%	5,476,255 $152 Million
Q3 2023 Oct 20, 2023	SELL	$27.17 - $31.97 $4.2 Million - $4.94 Million	-154,492 Reduced 2.68%	5,608,064 $157 Million
Q2 2023 Aug 11, 2023	SELL	$28.34 - $33.63 $7.11 Million - $8.44 Million	-250,865 Reduced 4.17%	5,762,556 $180 Million
Q1 2023 May 05, 2023	BUY	$25.31 - $29.02 $11.4 Million - $13.1 Million	451,615 Added 8.12%	6,013,421 $170 Million
Q4 2022 Feb 03, 2023	SELL	$21.94 - $26.24 $3.78 Million - $4.53 Million	-172,453 Reduced 3.01%	5,561,806 $145 Million
Q3 2022 Nov 02, 2022	BUY	$22.0 - $31.87 $8.28 Million - $12 Million	376,543 Added 7.03%	5,734,259 $128 Million
Q2 2022 Aug 02, 2022	BUY	$26.4 - $30.54 $2.61 Million - $3.02 Million	98,799 Added 1.88%	5,357,716 $160 Million
Q1 2022 May 12, 2022	SELL	$23.07 - $27.99 $6.46 Million - $7.83 Million	-279,823 Reduced 5.05%	5,258,917 $138 Million
Q4 2021 Jan 26, 2022	BUY	$21.47 - $32.08 $28 Million - $41.9 Million	1,306,461 Added 30.87%	5,538,740 $129 Million
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $84.8 Million - $117 Million	3,627,099 Added 599.34%	4,232,279 $131 Million
Q2 2021 Aug 09, 2021	SELL	$18.78 - $25.15 $639,834 - $856,860	-34,070 Reduced 5.33%	605,180 $14.8 Million
Q1 2021 May 12, 2021	BUY	$18.21 - $23.2 $884,459 - $1.13 Million	48,570 Added 8.22%	639,250 $11.9 Million
Q4 2020 Feb 11, 2021	BUY	$15.39 - $22.1 $5.59 Million - $8.03 Million	363,330 Added 159.81%	590,680 $11.8 Million
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $63,832 - $81,607	-3,950 Reduced 1.71%	227,350 $3.77 Million
Q2 2020 Jul 23, 2020	BUY	$13.31 - $19.41 $1.48 Million - $2.16 Million	111,400 Added 92.91%	231,300 $4.49 Million
Q1 2020 May 04, 2020	BUY	$13.06 - $21.24 $1.57 Million - $2.55 Million	119,900 New	119,900 $1.73 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$865 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$564 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$386 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$376 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$273 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.

Account